UK Markets open in 7 hrs 24 mins
  • NIKKEI 225

    27,548.00
    +159.80 (+0.58%)
     
  • HANG SENG

    27,321.98
    -401.82 (-1.45%)
     
  • CRUDE OIL

    72.27
    +0.20 (+0.28%)
     
  • GOLD FUTURES

    1,801.60
    -0.20 (-0.01%)
     
  • DOW

    35,061.55
    +238.15 (+0.68%)
     
  • BTC-GBP

    25,348.91
    +455.77 (+1.83%)
     
  • CMC Crypto 200

    786.33
    -7.40 (-0.93%)
     
  • Nasdaq

    14,836.99
    +152.39 (+1.04%)
     
  • ^FTAS

    4,025.12
    +33.64 (+0.84%)
     

Here's Why Everyone's Talking About Iovance Biotherapeutics

·4-min read
Here's Why Everyone's Talking About Iovance Biotherapeutics
  • Oops!
    Something went wrong.
    Please try again later.

Shares of Iovance Biotherapeutics (NASDAQ: IOVA) have been on a roller-coaster ride over the past few days. On May 18, Fardis notified the company she would be resigning "to pursue other opportunities." Iovance hasn't elaborated on the other opportunities Fardis will pursue, but they probably don't involve drug development.

Our goal is to create a safe and engaging place for users to connect over interests and passions. In order to improve our community experience, we are temporarily suspending article commenting